Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation
Induced pluripotent stem cell (iPSC)-derived T (iT) cells represent a groundbreaking frontier in adoptive cell therapies with engineered T cells, poised to overcome pivotal limitations associated with conventional manufacturing methods.iPSCs offer an off-the-shelf source of therapeutic T cells with the potential for infinite expansion and straightf